Suppr超能文献

腹腔镜根治性肾切除术:从T1期到巨大T2期肿瘤的历程

Laparoscopic radical nephrectomy: a journey from T1 to very large T2 tumors.

作者信息

Srivastava Aneesh, Gupta Manu, Singh Pratipal, Dubey Deepak, Mandhani Anil, Kapoor Rakesh, Kumar Anant

机构信息

Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

出版信息

Urol Int. 2009;82(3):330-4. doi: 10.1159/000209367. Epub 2009 May 11.

Abstract

OBJECTIVES

To evaluate the feasibility, efficacy and safety of laparoscopic radical nephrectomy (LRN) in T1 and T2 renal tumors.

PATIENTS AND METHODS

From December 1999 to March 2007, a retrospective analysis of 102 patients was done. A thorough preoperative workup was done in all patients. Postoperatively the patients were followed up every 3 months for the first year, 6-monthly for the next 2 years and yearly thereafter.

RESULTS

Transperitoneal radical nephrectomy was done in 85 patients, whereas 7 patients had a retroperitoneal surgery. A combined approach of retroperitoneal renal artery clipping followed by transperitoneal nephrectomy was done in 10 patients. 72 patients had clinically T1 tumors and 30 patients were T2 tumors. Mean tumor size was 6.97 cm, mean operative time was 174 min, mean blood loss was 230 ml, mean hospital stay was 4.6 days, and mean incision length was 8 cm. 19 patients had conversion to open surgery. Mean follow-up was 22.6 (range 4-56) months. Overall recurrence-free survival was 88.1%.

CONCLUSIONS

LRN is a safe and effective treatment for renal tumors with a steep learning curve. Large right-sided T2 tumors can be safely treated with the combined approach. Disease control rates with LRN are satisfactory.

摘要

目的

评估腹腔镜根治性肾切除术(LRN)治疗T1和T2期肾肿瘤的可行性、疗效及安全性。

患者与方法

对1999年12月至2007年3月期间的102例患者进行回顾性分析。所有患者均进行了全面的术前检查。术后第1年每3个月对患者进行随访,接下来2年每6个月随访一次,此后每年随访一次。

结果

85例患者行经腹根治性肾切除术,7例患者行腹膜后手术。10例患者采用腹膜后肾动脉阻断联合经腹肾切除术的联合方法。72例患者临床诊断为T1期肿瘤,30例患者为T2期肿瘤。肿瘤平均大小为6.97 cm,平均手术时间为174分钟,平均失血量为230 ml,平均住院时间为4.6天,平均切口长度为8 cm。19例患者中转开腹手术。平均随访时间为22.6(4 - 56)个月。总体无复发生存率为88.1%。

结论

LRN是一种治疗肾肿瘤安全有效的方法,但学习曲线较陡。大型右侧T2期肿瘤采用联合方法可安全治疗。LRN的疾病控制率令人满意。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验